Winter Park, Florida–(Newsfile Corp. – November 5, 2025) – Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today recaps its pivotal year-to-date achievements, marked by explosive revenue growth, strategic divestitures, and decisive steps toward full SEC reporting and a Nasdaq listing.

2025 Key Milestones

Q3 Revenue Surges Over 200% Quarter-Over-Quarter: On October 8, preliminary results showed revenue growth exceeding 100%, followed by the October 28 announcement confirming a 200%+ increase with profit margins above 20%, driven by strong demand for Adia Med clinics and Adia Labs regenerative products.

Source: Newsfile

SEC Form 10 Scheduled for Filing – Nasdaq Pathway Activated: Adia Nutrition has engaged an independent public accoun

See Full Page